Patents Assigned to Ampliwise Inc.
  • Patent number: 11827925
    Abstract: An embodiment relates to system comprising: (i) a reaction mixture comprises: a) a target nucleic acid molecule; b) a forward primer complementary to a strand of the target nucleic acid molecule, the forward primer comprises a first molecular moiety at a 3? end, wherein the first molecular moiety is non-complementary to the strand of the target nucleic acid molecule; c) a reverse primer complementary to a complementary sequence of the strand of the target nucleic acid molecule, the reverse primer comprises a second molecular moiety at a 3? end, wherein the second molecular moiety is non-complementary to the complementary sequence of the strand of the target nucleic acid molecule; d) a polymerase with 3?-5? exonuclease activity; and (ii a device suitable of detecting an amplification products.
    Type: Grant
    Filed: December 31, 2020
    Date of Patent: November 28, 2023
    Assignee: AMPLIWISE INC.
    Inventors: Kai Wu, Mindy Su, Xing Su
  • Patent number: 11377682
    Abstract: The disclosure provides compositions and methods for amplifying and/or analyzing nucleic acids.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: July 5, 2022
    Assignee: Ampliwise Inc.
    Inventors: Kai Wu, Mindy Su, Xing Su
  • Patent number: 10907200
    Abstract: The disclosure provides compositions and methods for amplifying nucleic acids.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: February 2, 2021
    Assignee: Ampliwise Inc.
    Inventors: Kai Wu, Mindy Su, Xing Su